The Small Interfering Ribonucleic Acid (RNA) Market Projected to Reach $39.26 Billion with a 20.1% CAGR by 2029
The Business Research Company
The Business Research Company’s Small Interfering Ribonucleic Acid (RNA) Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, December 16, 2025 /EINPresswire.com/ -- The small interfering ribonucleic acid (siRNA) market is rapidly evolving, driven by significant advancements in genetic research and therapeutic applications. As healthcare increasingly embraces personalized medicine, the demand for siRNA-based treatments is set to soar, reshaping the pharmaceutical landscape. Let’s explore the market’s current status, key growth factors, major players, and regional dynamics shaping its future.
Market Size and Growth Forecast for the Small Interfering Ribonucleic Acid (RNA) Market
In recent years, the small interfering ribonucleic acid (RNA) market has experienced remarkable expansion. It is projected to increase from $15.65 billion in 2024 to $18.86 billion in 2025, with an impressive compound annual growth rate (CAGR) of 20.5%. This growth during the historic period is largely fueled by rising government investments, growing awareness about genetic disorders, an increase in clinical trials focused on siRNA therapies, expansion of biotechnology infrastructure, and broader acceptance of targeted therapeutic approaches.
Looking ahead, the market is expected to reach $39.26 billion by 2029, maintaining a strong CAGR of 20.1%. The anticipated growth is driven by factors such as heightened demand for personalized medicine, greater funding directed toward siRNA research, strategic collaborations between pharmaceutical companies, and more approvals of siRNA-based drugs. Key trends emerging in this period include breakthroughs in delivery technologies, innovations in RNA interference therapeutics, advances in lipid nanoparticle carriers, ongoing research in gene silencing mechanisms, and improvements in targeted drug delivery systems.
Download a free sample of the small interfering ribonucleic acid (rna) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30394&type=smp
Understanding Small Interfering Ribonucleic Acid (RNA) and Its Role
Small interfering ribonucleic acid (siRNA) consists of short double-stranded RNA molecules that play a crucial role in gene silencing through RNA interference (RNAi). siRNA binds to specific messenger RNA (mRNA) sequences, targeting them for degradation and thereby preventing the production of certain proteins. This mechanism allows siRNA to regulate or suppress specific gene expressions, making it a powerful tool in both research and therapeutic contexts, especially for targeting genes linked to diseases.
Key Factors Propelling the Small Interfering Ribonucleic Acid (RNA) Market
One of the biggest drivers for the siRNA market is the rising interest in personalized medicine. This approach customizes medical treatments based on an individual’s unique genetic makeup, environment, and lifestyle factors to achieve better clinical results. Advances in genomic technologies have made it possible to identify genetic variations with high precision, enabling treatments tailored to each patient’s needs.
siRNA fits perfectly into this model by allowing highly specific gene silencing, which enhances the effectiveness of therapies and minimizes off-target effects. This targeted inhibition of disease-related mRNA translates into improved therapeutic outcomes. For example, in February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, a significant jump from 12 approvals in 2022. Such milestones reinforce the growing role of personalized medicine in driving siRNA market expansion.
View the full small interfering ribonucleic acid (rna) market report:
https://www.thebusinessresearchcompany.com/report/global-small-interfering-ribonucleic-acid-rna-market-report
Regions Leading the Small Interfering Ribonucleic Acid (RNA) Market
In 2024, North America held the largest share of the small interfering ribonucleic acid (RNA) market. The global market landscape also includes important regions such as Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East, and Africa. Each of these regions contributes to the overall growth by advancing research, expanding infrastructure, and adopting siRNA-based medical solutions.
Browse Through More Reports Similar to the Global Small Interfering Ribonucleic Acid (RNA) Market 2025, By The Business Research Company
Ribonucleic Acid Rna Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report
Ribose Nucleic Acid Rna Based Therapeutics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ribose-nucleic-acid-rna-based-therapeutics-global-market-report
Nucleic Acid Isolation And Purification Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/nucleic-acid-isolation-and-purification-global-market-report
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
